drugset / Trial / NCT06508099
Vitamin A and D Supplementation in Allogeneic HCT
RandomizedParallel-groupOpen-labelTreatment
Summary
The therapy under investigation is the addition of 300 000 IU of vitamin A and 100 000 IU of vitamin D before conditioning. The study will include patients with malignant diseases in hematologic response with indications for allogeneic transplantation with matched related or matched unrelated donor.
Timeline
- Start
- 2024-05-15
- Primary completion
- 2026-05
- Completion
- 2027-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | 100000 iu | Oral |
| Subject | Vitamin A | Unknown | 300000 iu | Oral |